Access to anti-retroviral drugs, female in Ecuador
Ecuador: Access to anti-retroviral drugs, female was 75.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Ecuador, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Ecuador recorded 75.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
The figure is up 1.4% on the previous year and up 92.3% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Ecuador peaked at 75.0% in 2024 and was at its lowest, 2.0%, in 2000.
Ecuador ranks 67th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Ecuador, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 2.0% | — |
| 2001 | 2.0% | +0.0% |
| 2002 | 2.0% | +0.0% |
| 2003 | 2.0% | +0.0% |
| 2004 | 3.0% | +50.0% |
| 2005 | 4.0% | +33.3% |
| 2006 | 5.0% | +25.0% |
| 2007 | 8.0% | +60.0% |
| 2008 | 11.0% | +37.5% |
| 2009 | 14.0% | +27.3% |
| 2010 | 17.0% | +21.4% |
| 2011 | 20.0% | +17.6% |
| 2012 | 23.0% | +15.0% |
| 2013 | 33.0% | +43.5% |
| 2014 | 39.0% | +18.2% |
| 2015 | 44.0% | +12.8% |
| 2016 | 43.0% | -2.3% |
| 2017 | 49.0% | +14.0% |
| 2018 | 55.0% | +12.2% |
| 2019 | 64.0% | +16.4% |
| 2020 | 70.0% | +9.4% |
| 2021 | 69.0% | -1.4% |
| 2022 | 70.0% | +1.4% |
| 2023 | 74.0% | +5.7% |
| 2024 | 75.0% | +1.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.3% | 2.0% | 14.0% | 10 |
| 2010s | 38.7% | 17.0% | 64.0% | 10 |
| 2020s | 71.6% | 69.0% | 75.0% | 5 |
Countries ranked near Ecuador
More gender data for Ecuador
- Child population (UN estimates and projections) 4,113 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.8663 % change on previous year (2030)
- Population 14,957 (2030)
- Working-age population (UN estimates and projections) 14,957 (2030)
- Population (UN estimates and projections), annual growth rate 1.3 % change on previous year (2030)
- Age population, age 00, female, interpolated 129,930 (2025)
- Age population, age 00, male, interpolated 135,561 (2025)
- Age population, age 01, female, interpolated 130,156 (2025)
- Age population, age 01, male, interpolated 135,822 (2025)
- Age population, age 02, female, interpolated 131,369 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Ecuador?
- Access to anti-retroviral drugs, female in Ecuador was 75.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Ecuador?
- The highest recorded value was 75.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Ecuador?
- The lowest recorded value was 2.0% in 2000.
- How does Ecuador rank for access to anti-retroviral drugs, female?
- Ecuador ranks 67th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Ecuador?
- Over the last ten years it is up 92.3%. The long-run trend across the full record is volatile.
- Where does this Ecuador data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.